Efonidipine Hydrochloride: A New Calcium Antagonist
- 1 June 1994
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 12 (2), 123-135
- https://doi.org/10.1111/j.1527-3466.1994.tb00287.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of a Newly Synthesized Dihydropyridine, NZ-105, on Intracellular Ca Transients and Tension in Ferret Ventricular MusclesJournal of Cardiovascular Pharmacology, 1994
- Effect of efonidipine hydrochloride(NZ-105), a new dihydropyridine calcium antagonist, on the experimental atherosclerosis in cholesterol-fed rabbits.Folia Pharmacologica Japonica, 1994
- Effects of Long-term Oral Administration of NZ-105, a Novel Calcium Antagonist, With or Without Propranolol in Spontaneously Hypertensive RatsJournal of Pharmacy and Pharmacology, 1993
- Effects of NZ-105, a New Calcium Antagonist, on Renal Function in Anesthetized Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1992
- Affinity of Z-105 to the 1,4-dihydropyridine type calcium channel and several other receptor bindings in the central nervous system.Folia Pharmacologica Japonica, 1992
- NZ-105, a New 1,4-Dihydropyridine Derivative: Correlation between Dihydropyridine Receptor Binding and Inhibition of Calcium Uptake in Rabbit Aorta.The Japanese Journal of Pharmacology, 1991
- Pharmacokinetics and Safety of NZ-105 in Healthy Volunteers: Single-Dose and Multiple-Dose Studies.Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1991
- Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogsXenobiotica, 1987
- Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension.Journal of Clinical Investigation, 1986
- Biotransformation of 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridinedicarboxylic acid diethyl esterJournal of Medicinal Chemistry, 1973